Australian trial unveils blood test to personalize ovarian cancer therapy

MELBOURNE, Nov. 12 (Xinhua) -- Australian scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying women more likely to respond to an ovarian cancer treatment known as PARP inhibitor therapy. The breakthrough stems from the...